For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Cognition Therapeutics Inc’s stock clocked out at $0.41, down -4.20% from its previous closing price of $0.43. In other words, the price has decreased by -$4.20 from its previous closing price. On the day, 0.65 million shares were traded.
Ratios:
To gain a deeper understanding of CGTX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.11 and its Current Ratio is at 2.11. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, B. Riley Securities on December 19, 2024, Upgraded its rating to Buy and sets its target price to $1.50 from $1 previously.
On November 03, 2021, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $22.Oppenheimer initiated its Outperform rating on November 03, 2021, with a $22 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 31 ’25 when Ricciardi Lisa bought 38,851 shares for $0.77 per share. The transaction valued at 30,001 led to the insider holds 38,851 shares of the business.
Ricciardi Lisa bought 5,700 shares of CGTX for $9,975 on Mar 14 ’24. The CEO & President now owns 291,345 shares after completing the transaction at $1.75 per share.
Stock Price History:
Over the past 52 weeks, CGTX has reached a high of $2.95, while it has fallen to a 52-week low of $0.34. The 50-Day Moving Average of the stock is -36.59%, while the 200-Day Moving Average is calculated to be -54.79%.
Shares Statistics:
A total of 40.81M shares are outstanding, with a floating share count of 33.67M. Insiders hold about 18.96% of the company’s shares, while institutions hold 12.30% stake in the company.
